Articles From: Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners to Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results


http://media.marketwire.com/attachments/200805/430382_ProspectCapitalLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147678&ProfileId=051205&sourceType=1 NEW YORK, NY --
Sign-up for Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners investment picks
Rudolph Technologies, Inc. (NYSE: RTEC) announced today that Michael Plisinski, vice president and general manager of the Company’s Data Analysis and Review Business Unit has been appointed executive vice president and chief operating officer (COO) effective October 1, 2014.
Sign-up for Rudolph Technologies Appoints Michael Plisinski as Chief Operating Officer investment picks
Development Kit Features Two FPGA Mezzanine Card Headers for Off-the-shelf Daughter Cards and Comes with Complimentary Libero Platinum Development License ALISO VIEJO, Calif.
Sign-up for Microsemi Expands Customer Application Design Opportunities by Introducing SmartFusion2 Advanced Development Kit with Largest Density 150K LE Device investment picks
http://media.marketwire.com/attachments/201305/60668_insys.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147673&ProfileId=051205&sourceType=1 PHOENIX, AZ --
Sign-up for Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioma investment picks
2014/9/29
At the 60th Annual ASIS International Seminar and Exhibit, the Bruker Detection division introduces RoadRunner™ , an innovative, hand-held explosives and narcotics trace detector with outstanding sensitivity, selectivity, analyte coverage and ease of use.
Sign-up for Bruker Introduces RoadRunner™, a Novel High-Performance Hand-Held Explosives and Narcotics Trace Detector investment picks
2014/9/29
HOUSTON , Sept.
Sign-up for Flotek Industries Announces Upcoming Presentation at Johnson Rice Energy Conference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970227001&sourceType=1 http://media3.marketwire.com/logos/20130605-RioAlto.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Rio Alto Completes 2014 Oxide Drilling Program at La Arena investment picks
IRVINE, Calif., Sept.
Sign-up for Endologix Completes Enrollment in EVAS FORWARD - Global Registry investment picks
Accelerates transformation of AMAG to a Profitable, Multi-Product Specialty Pharmaceutical Company Adds FDA-Approved Therapy Makena® and Complementary Commercial Platform to AMAG Portfolio Projected Pro Forma Combined 2015 Revenues of $350 million and Estimated Annual Cost Synergies of at least $20 million Transaction Expected to be Immediately Accretive to Adjusted Earnings Per Share Conference Call Today at 8am ET to Discuss Transaction WALTHAM, Mass., Sept.
Sign-up for AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business investment picks
LEOPARD Study to Enroll 600 Patients to Provide a "Real-World" Head-to-Head Comparison of the AFX® System Versus Other Commercially Available EVAR Devices IRVINE, Calif., Sept.
Sign-up for Endologix to Initiate First Ever Comparative Randomized EVAR Study investment picks
Shares of Athlon Energy Inc. (ATHL) surged 24% in premarket action on Monday after news that Canada's Encana Corp.
Sign-up for Athlon shares soar 24% premarket after Encana deal investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received ADCETRIS (brentuximab vedotin) as consolidation therapy immediately following an autologous stem cell transplantation (ASCT) lived significantly longer without disease progression compared to patients who received placebo.
Sign-up for Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for Consolidation in Post-Transplant Hodgkin Lymphoma investment picks
IRVINE, Calif., Sept.
Sign-up for Sabra Health Care REIT Announces Public Offering of 6,000,000 Shares of Common Stock investment picks
HIGHLIGHTS Consists of 21 independent living facilities, 100% private pay 2,850 units located in 15 states 7.14% GAAP lease yield Annual rent escalators of 4.0% in years 2 and 3, the greater of CPI and 3.5% thereafter Credit enhancement from substantial guarantor entity including fixed charge coverage and other covenants This acquisition creates a significant shift in our portfolio composition and increases our total annualized revenues by 23.0% (pro forma as of June 30, 2014): IRVINE, Calif., Sept.
Sign-up for Sabra Acquires Portfolio of 21 Independent Living Facilities in Sale/Leaseback Transaction From Affiliates of Holiday Retirement investment picks
2014/9/29
HOUSTON , Sept.
Sign-up for Columbia Pipeline Partners LP Files for Initial Public Offering investment picks
Fully self-serviceable business logic for the Akamai Intelligent Platform improves developer time to market, infrastructure scale and page load times CAMBRIDGE, Mass.
Sign-up for Akamai Introduces new Cloudlets to Simplify the Development and Delivery of Fast and Secure Multi-screen Web Experiences investment picks
Integrated Work Process Solutions Allow MEP Service Contractors to Efficiently Manage Their Mobile Service Workforce CHICAGO , Sept.
Sign-up for Trimble Integrates its Field Service Management Suite and Mechanical, Electrical and Plumbing Time & Material Billing Software to Boost Productivity investment picks
Unwired Planet, Inc. (NASDAQ:UPIP), today announced that Eric Vetter intends to resign as the company’s president, chief financial officer and chief administrative officer as of November 18, 2014.
Sign-up for Unwired Planet Announces Management Transition Plan investment picks
2014/9/29
By Barbara Kollmeyer, MarketWatch MADRID (MarketWatch) -- U.S. stock futures were under pressure on Monday, on unrest in Hong Kong, an even-stronger dollar gains and expectations for strong jobs data later in the week.
Sign-up for UPDATE: U.S. stocks: Futures fall amid Hong Kong unrest, data jitters investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0970237001&sourceType=1 http://media3.marketwire.com/logos/20130625-serinus_logo_update_200.jpg CALGARY, ALBERTA --
Sign-up for Serinus Energy Inc.-Ukraine: Impact of New Ukrainian Banking Regulations investment picks
2014/9/29
By Shawn Langlois, MarketWatch Dip buyers get ready, your favorite dish is about to be served.
Sign-up for Get ready, dip-buyers -- the fourth quarter should offer plenty of opportunities investment picks
MCLEAN, Va.
Sign-up for CYREN Named to Deloitte 2014 Israel Technology Fast 50 investment picks
2014/9/29
By Curtis S.
Sign-up for UPDATE: The most important thing Alibaba's U.S. listing will do for China investment picks
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with non-small cell lung cancer (NSCLC) with HER2 mutations was presented today as a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2014 Congress, taking place in Madrid, Spain.
Sign-up for Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Announces Approval of Its AXP(R) AutoXpress(R) System in Taiwan investment picks
RANCHO CORDOVA, Calif., Sept.
Sign-up for Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Prospect Capital Provides $215 Million of First Lien Senior Secured Credit Facilities to Pacific World Corporation, a Portfolio Company of Levine Leichtman Capital Partners to Cesca Therapeutics Reports Fourth Quarter and Full Fiscal 2014 Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent